Author:
Healy Katie,Pavesi Andrea,Parrot Tiphaine,Sobkowiak Michał J.,Reinsbach Susanne E.,Davanian Haleh,Tan Anthony T.,Aleman Soo,Sandberg Johan K.,Bertoletti Antonio,Sällberg Chen Margaret
Funder
National Medical Research Council
Science for Life Laboratory
Ministry of Health -Singapore
Erik och Edith Fernströms Stiftelse för Medicinsk Forskning
Swedish Cancer Society
Karolinska Institutet
Vetenskapsrådet
Knut and Alice Wallenberg Foundation
Subject
Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine
Reference54 articles.
1. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015;Akinyemiju;JAMA Oncol,2017
2. Hepatocellular carcinoma: a review;Balogh;J Hepatocell Carcinoma,2016
3. Hepatocellular carcinoma review: current treatment, and evidence-based medicine;Raza;World J Gastroenterol,2014
4. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial;El-Khoueiry;Lancet,2017
5. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial;Zhu;Lancet Oncol,2018
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献